|
SFRS6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.704300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.377200E-03 |
| Normal-vs-Stage2 |
2.561200E-01 |
| Normal-vs-Stage3 |
5.649600E-02 |
| Normal-vs-Stage4 |
1.238040E-02 |
| Stage1-vs-Stage2 |
8.231400E-01 |
| Stage1-vs-Stage3 |
7.714800E-01 |
| Stage1-vs-Stage4 |
4.669200E-01 |
| Stage2-vs-Stage3 |
7.449000E-01 |
| Stage2-vs-Stage4 |
5.332800E-01 |
| Stage3-vs-Stage4 |
6.718200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.187790E-02 |
| Normal-vs-AfricanAmerican |
4.372400E-02 |
| Normal-vs-Asian |
2.389800E-01 |
| Caucasian-vs-AfricanAmerican |
9.862400E-01 |
| Caucasian-vs-Asian |
9.736000E-01 |
| AfricanAmerican-vs-Asian |
9.676000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.536000E-03 |
| Normal-vs-Female |
7.322200E-02 |
| Male-vs-Female |
6.117800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.190100E-02 |
| Normal-vs-Extreme_Weight |
1.683690E-03 |
| Normal-vs-Obese |
8.441600E-02 |
| Normal-vs-Extreme_Obese |
2.662100E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.560400E-01 |
| Normal_Weight-vs-Obese |
7.163000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.250000E-01 |
| Extreme_Weight-vs-Obese |
2.851200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.597800E-01 |
| Obese-vs-Extreme_Obese |
2.606600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.492100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.097370E-01 |
| Normal-vs-Age(61-80Yrs) |
5.255300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.93720000000375E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.073000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.977600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.223900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.923380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.957750E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.880400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.498810E-01 |
| Normal-VS-Type2 PRCC |
1.8587999994768E-07 |
| Normal-VS-KIRP CIMP |
3.50020000000617E-05 |
| Normal-VS-Unclassified PRCC |
6.281200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.93979999951743E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.096800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.308400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.279800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.924500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.084500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.021800E-04 |
| Normal-vs-N1 |
4.120400E-01 |
| Normal-vs-N2 |
1.595530E-04 |
| N0-vs-N1 |
2.386400E-01 |
| N0-vs-N2 |
6.993900E-02 |
| N1-vs-N2 |
8.165900E-02 |
|
|
